Zivo Bioscience Stock Forecast - Daily Balance Of Power

ZIVOWDelisted Stock  USD 0.55  0.07  14.58%   
Zivo Stock Forecast is based on your current time horizon.
  
On May 22, 2023 Zivo Bioscience Warrants had Daily Balance Of Power of 0.5. Balance of Power indicator (or BOP) measures the strength of Zivo Bioscience Warrants market sensitivity to bulls and bears. It estimates the ability of Zivo Bioscience buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Zivo Bioscience Balance of Power indicator one can determine a trend of the price direction.
Check Zivo Bioscience VolatilityBacktest Zivo BioscienceTrend Details  

Zivo Bioscience Trading Date Momentum

On May 24 2023 Zivo Bioscience Warrants was traded for  0.57  at the closing time. The highest daily price throughout the period was 0.57  and the lowest price was  0.57 . The daily volume was 160. The net trading volume on 05/24/2023 added to the next day price increase. The trading date delta to closing price of the next trading day was 3.64% . The trading date delta to current closing price is 12.73% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Zivo Bioscience to competition

Zivo Bioscience Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zivo Bioscience stock to make a market-neutral strategy. Peer analysis of Zivo Bioscience could also be used in its relative valuation, which is a method of valuing Zivo Bioscience by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Zivo Bioscience Market Strength Events

Market strength indicators help investors to evaluate how Zivo Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zivo Bioscience shares will generate the highest return on investment. By undertsting and applying Zivo Bioscience stock market strength indicators, traders can identify Zivo Bioscience Warrants entry and exit signals to maximize returns.

Zivo Bioscience Risk Indicators

The analysis of Zivo Bioscience's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Zivo Bioscience's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting zivo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in Zivo Stock

If you are still planning to invest in Zivo Bioscience Warrants check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing